Annals of Neurology Version of Record online: 10 AUG 2016. DOI: 10.1002/ana.24748
Martyn K. White D.Phil.1, Hassen S. Wollebo Ph.D.1, J. David Beckham M.D.2,3, Kenneth L. Tyler M.D.2,3,4 andKamel Khalili Ph.D.1,*
Publishers wants $6 to rent the final PDF
 Download the Accepted PDF from VitaminDWiki
Nothing about Vitamin D
CONFLICT OF INTEREST is of interest
Dr. Khalili is a scientific advisor and holds equity in Excision Biotherapeutics, a biotech start-up
who has licensed the viral gene editing technology from Temple University for commercial
development and clinical trials